
Cryoport Systems Named Finalist in Four Categories at Asia-Pacific Biopharma Excellence Awards 2026
We’re thrilled to announce that Cryoport Systems has been named a finalist in four categories for the upcoming Asia-Pacific Biopharma Excellence Awards 2026. These nominations reflect our unwavering commitment to innovation and excellence in supporting the global biopharma community.
The categories include:
- Best Logistics & Supply Chain Management Supplier Award: Temperature Monitoring Solution
- Best Logistics & Supply Chain Management Supplier Award: Last Mile Implementation
- Best Logistics & Supply Chain Management Supplier Award: Digital Technology & Software
- Best Logistics & Supply Chain Management Supplier Award: Clinical Trial Logistics
Being shortlisted in these diverse areas demonstrates the true breadth and depth of our capabilities. From advanced continuous monitoring solutions that safeguard temperature-sensitive therapies, to robust last-mile strategies that ensure secure delivery, to cutting-edge digital platforms like our Cryoportal® logistics management system that streamlines supply chain visibility, and an end-to-end supply chain management platform that supports clinical trial logistics, Cryoport Systems is proud to set the standard for excellence.
At Cryoport Systems, we understand that every shipment represents hope for patients and progress for science. That’s why we continually invest in the technology and global infrastructure to Enable the Outcome™ for our clients and the patients they serve.
Now, we need your support! Voting is open for the Asia-Pacific Biopharma Excellence Awards, and your voice can help us bring these honors home. By voting for Cryoport Systems, you’re endorsing a future where logistics and supply chain excellence empower breakthroughs in healthcare.
Click here to cast your vote: https://info.imapac.com/awards/abea2026-voting/bsca2026
Thank you to our clients, partners, and team members for making this possible. Together, we’re Enabling the Outcome™, one innovation at a time.